Randomised controlled trial of low dose rivaroxaban in advanced chronic kidney disease @georgeinstitute PIs @Badves @kidneybloke
International trial
Joined May 2019
- Tweets137
- Following164
- Followers223
- Likes128
Pinned Tweet
Watch this #NephGR presentation from @Badves to learn the background , rationale and methodology of the TRACK trial.
Did you miss @Badves excellent #NephGR presentation on the @TRACK_trial ?
We got you covered here youtu.be/NAySJkiwpCM
The TRACK Trial retweeted
Grand succès pour la mise en place de l'étude @TRACK_trial en collaboration avec le @georgeinstitute , le @CHRU_de_Nancy et @INICRCT !
The TRACK Trial retweeted
Do you want to know more about @TRACK_trial ? Watch this video to understand why is this trial so important for patients with advanced stages of CKD and kidney failure.
Did you miss @Badves excellent #NephGR presentation on the @TRACK_trial ?
We got you covered here youtu.be/NAySJkiwpCM
The TRACK Trial retweeted
Today's #NephGR at @UOttawaMed and @OttawaHospital will be on the topic of 'Anti-thrombotic targets in advanced stages of kidney disease' from @Badves of the @georgeinstitute @TRACK_trial
We have reached another milestone. 500 patients randomised! Congratulations to all principal investigators and study coordinators. Our national leaders are @LilyMshar in Malaysia, @vjha126 and @raja_1980 in India, @jardine_meg in Australia 1/-
@mohammedtawhari @Ahmed_Shaman and Majed Al Jeraisy in Saudi Arabia, Habib Skhiri in Tunisia, @adrianliew8 in Singapore, Hung-Chun Chen in Taiwan, @lastwalsh and @Msood99M in Canada, Patrick Rossignol in France Jan Menne in Germancy, An De Vriese in Belgium. 2/-
Congratulations and thank you to all Indian site investigators and coordinators for recruiting 200 participants. Our top recruiting investigators are-
Dr Vinay Rathore (AIIMS Raipur)
Dr R Ramachandran (PGIMER Chandigarh)
Dr Manisha Sahay (Osmania Hospital)
- 1/3
Dr Atanu Pal (IPGMER Kolkata)
Dr Sree Bhushan Raju (NIMS Hyderabad)
Dr Saurabh Nayak (AIIMS Bhatinda)
Dr Avinash Ignatius (Noble Annex Hospital Pune)
Dr Suresh Sankar (VS Hospital Chennai)
Dr Ramaswami Sethuraman (KG Hospital Coimbatore)
Dr Umapati Hegde (MPUH Nadiad)
-2/3
Dr Seerapani (Citizens Hospital Telangana)
Dr Sashidhar Chennamsetty (Govt Hospital)
Dr Balaraman (Aysha Hospital).
Also congratulation and thank you @vjha126 @raja_1980 for your leadership and the dedicated @GeorgeInstIN staff for reaching this major milestone.
Congratulations to all Malaysian investigators and coordinators for randomising 200 participants from Malaysia in @TRACK_trial Under the leadership of Dr @LilyMshar Malaysia is leading the recruitment.
We have reached a new milestone! Over 400 participants randomised in @TRACK_trial. Strong recruitment record in Malaysia led by @LilyMshar; India by @raja_1980 @drmanishasahay Dr Vinay Rathore; Saudi Arabia by @mohammedtawhari and @Ahmed_Shaman
The TRACK Trial retweeted
#ResearchLetter: Rivaroxaban 2.5 mg twice daily plus aspirin reduces venous thromboembolism in patients with chronic atherosclerosis @PHRIresearch #AHAJournals ahajrnls.org/39QLrgb
The TRACK Trial retweeted
More benefits noted in the COMPASS trial - reductions in venous thromboembolism as well. Now in @CircAHA. @PHRIresearch Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis ahajournals.org/doi/10.1161/…
Congratulations to Drs Majed Al Jeraisy, Mohammed Tawhari and @Ahmed_Shaman from @kaimrc_ksa for enrolling their FIRST three patients in TRACK. We welcome Saudi Arabia 🇸🇦 to the TRACK trial.
The TRACK Trial retweeted
New paper from @PHRIresearch - Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial academic.oup.com/ehjcvp/adva… #CardioTwitter
Congratulations all the investigators. We have just randomised 300th participant in @TRACK_trial
Under the leadership of @LilyMshar the Malaysian sites have enrolled more than 160 participants
Under the leadership of @vjha126 and @raja_1980 the Indian sites have enrolled more than 100 participants.
